Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.

STUDY OBJECTIVES Increased oxidant burden is involved in the pathogenesis of COPD. Glutathione (GSH) is a major antioxidant scavenging reactive oxygen and nitrogen species. We studied the concentrations of total and reduced GSH, glutathione disulfide (GSSG), and nitrosothiols in sputum supernatant of patients with COPD. DESIGN Twenty-five patients with moderate-to-severe COPD (FEV(1) 61 +/- 12% of predicted) and 25 healthy nonsmoking control subjects underwent sputum induction. Sputum total GSH and GSSG were measured spectrophotometrically, and nitrosothiols were quantified by enzyme assay. Exhaled nitric oxide (eNO) was also measured to correlate eNO with nitrosothiols in induced sputum. MEASUREMENTS AND RESULTS Compared with healthy subjects, patients with COPD had increased sputum neutrophils (geometric mean, 65%; 95% confidence interval [CI], 57.5 to 71; vs 21%; 95% CI, 13.2 to 31.6; p < 0.001); total GSH (geometric mean, 7.1 micromol/L; 95% CI, 2.95 to 17; vs 5.1 micromol/L; 95% CI, 3.2 to 8.1; p = 0.024); GSSG (geometric mean, 4.1 micromol/L; 95% CI, 1.7 to 10; vs 0.84 micromol/L; 95% CI, 0.35 to 1.99; p = 0.002); and nitrosothiols (geometric mean, 60.4 micromol/L; 95% CI, 40 to 95.5; vs 38 micromol/L; 95% CI, 31.6 to 43.6; p = 0.04). Sputum GSSG was positively correlated with neutrophils (rho = 0.47, p = 0.016) and nitrosothiols (rho = 0.49, p = 0.024) in patients with COPD, whereas there was no correlation of eNO with nitrosothiols (rho = 0.38, p = 0.1). CONCLUSIONS Sputum concentrations of GSSG and nitrosothiols are increased in patients with COPD and associated with neutrophilic inflammation. These data underline the role of oxidative stress in the pathogenesis of COPD, and suggest that GSH is important to scavenge both reactive oxygen and nitrogen species.

[1]  K. Ohlsson,et al.  Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity , 1989, Inflammation.

[2]  K. Hirata,et al.  Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease , 2003, Thorax.

[3]  R. Buhl,et al.  Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis , 2002, European Respiratory Journal.

[4]  W. MacNee,et al.  Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy. , 2008, Novartis Foundation symposium.

[5]  I. Pavord,et al.  Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. , 2001, Respiratory medicine.

[6]  N. Ganguly,et al.  Increased nitric oxide production by neutrophils in bronchial asthma. , 2001, The European respiratory journal.

[7]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[8]  M. Decramer,et al.  The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. , 2001, The European respiratory journal.

[9]  P. Montuschi,et al.  Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. , 2001, American journal of respiratory and critical care medicine.

[10]  J. Bargon,et al.  Glutathione in induced sputum of healthy individuals and patients with asthma , 2001, Thorax.

[11]  J. Steurer,et al.  The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. , 2000, The European respiratory journal.

[12]  H. Magnussen,et al.  Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[13]  W. MacNee,et al.  Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. , 1999, American journal of respiratory and critical care medicine.

[14]  C. Cross,et al.  Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[15]  F. Kelly,et al.  Measurement of antioxidants, oxidants and oxidant products in bronchoalveolar lavage fluid. , 1999 .

[16]  M. Grisham,et al.  Superoxide released from neutrophils causes a reduction in nitric oxide gas. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[17]  Kanazawa,et al.  Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  J. Stamler,et al.  Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure , 1998, The Lancet.

[19]  A. Sinclair,et al.  Glutathione: in sickness and in health , 1998, The Lancet.

[20]  F. Hargreave,et al.  Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. , 1997, The European respiratory journal.

[21]  S. Tannenbaum,et al.  The chemistry of the S-nitrosoglutathione/glutathione system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D G Altman,et al.  Statistics notes: Transformations, means, and confidence intervals , 1996, BMJ.

[23]  W. MacNee,et al.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. , 1996, Thorax.

[24]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Smith,et al.  Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. , 1993, The American review of respiratory disease.

[26]  R. Crystal Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. , 1991, The American journal of medicine.

[27]  R. Crystal,et al.  Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis , 1991, The Lancet.

[28]  W. MacNee,et al.  Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. , 1991, Thorax.

[29]  R. Crystal,et al.  SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.

[30]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[31]  R. Crystal,et al.  Normal alveolar epithelial lining fluid contains high levels of glutathione. , 1987, Journal of applied physiology.